HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.

AuthorsXiaodong Li, Yuxiao Hong, Qian An, John Chen, Huachen Wei, Hong-Duo Chen, Xing-Hua Gao
JournalJAMA dermatology (JAMA Dermatol) Vol. 149 Issue 8 Pg. 992-3 (Aug 2013) ISSN: 2168-6084 [Electronic] United States
PMID23783880 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunosuppressive Agents
  • Thalidomide
Topics
  • Administration, Oral
  • Adult
  • Dose-Response Relationship, Drug
  • Follow-Up Studies
  • Histiocytosis, Sinus (drug therapy, pathology)
  • Humans
  • Immunosuppressive Agents (administration & dosage, therapeutic use)
  • Male
  • Skin Diseases (drug therapy, pathology)
  • Thalidomide (administration & dosage, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: